(R)-ketamine restores anterior insular cortex activity and cognitive deficits in social isolation-reared mice
- PMID: 38388704
- PMCID: PMC11189812
- DOI: 10.1038/s41380-024-02419-6
(R)-ketamine restores anterior insular cortex activity and cognitive deficits in social isolation-reared mice
Abstract
Chronic social isolation increases the risk of mental health problems, including cognitive impairments and depression. While subanesthetic ketamine is considered effective for cognitive impairments in patients with depression, the neural mechanisms underlying its effects are not well understood. Here we identified unique activation of the anterior insular cortex (aIC) as a characteristic feature in brain-wide regions of mice reared in social isolation and treated with (R)-ketamine, a ketamine enantiomer. Using fiber photometry recording on freely moving mice, we found that social isolation attenuates aIC neuronal activation upon social contact and that (R)-ketamine, but not (S)-ketamine, is able to counteracts this reduction. (R)-ketamine facilitated social cognition in social isolation-reared mice during the social memory test. aIC inactivation offset the effect of (R)-ketamine on social memory. Our results suggest that (R)-ketamine has promising potential as an effective intervention for social cognitive deficits by restoring aIC function.
© 2024. The Author(s).
Conflict of interest statement
KH is the inventor of filed patent applications on “The use of R-ketamine in the treatment of psychiatric diseases,” “(S)-norketamine and salt thereof as pharmaceutical,” “R-ketamine and derivative thereof as prophylactic or therapeutic agent for neurodegeneration disease or recognition function disorder,” “Preventive or therapeutic agent and pharmaceutical composition for inflammatory diseases or bone diseases,” and “R-ketamine and its derivatives as a preventive or therapeutic agent for a neurodevelopmental disorder” by the Chiba University. KH has also received speakers’ honoraria, consultant fees, or research support from Abbott, Boehringer Ingelheim, Daiichi-Sankyo, Meiji Seika Pharma, Seikagaku Corporation, Dainippon-Sumitomo, Taisho, Otsuka, Murakami Farm and Perception Neuroscience. All other authors declare they have no competing interests.
Figures




References
-
- Loades ME, Chatburn E, Higson-Sweeney N, Reynolds S, Shafran R, Brigden A, et al. Rapid systematic review: the impact of social isolation and loneliness on the mental health of children and adolescents in the context of COVID-19. J Am Acad Child Adolesc Psychiatry. 2020;59:1218–39. doi: 10.1016/j.jaac.2020.05.009. - DOI - PMC - PubMed
MeSH terms
Substances
Grants and funding
- JP20H03391/MEXT | Japan Society for the Promotion of Science (JSPS)
- JP22H05080/MEXT | Japan Society for the Promotion of Science (JSPS)
- JP23H02640/MEXT | Japan Society for the Promotion of Science (JSPS)
- JP22J13259/MEXT | Japan Society for the Promotion of Science (JSPS)
- JP22KJ2161/MEXT | Japan Society for the Promotion of Science (JSPS)
- JP20H03392/MEXT | Japan Society for the Promotion of Science (JSPS)
- JP21K19714/MEXT | Japan Society for the Promotion of Science (JSPS)
- JP20H00492/MEXT | Japan Society for the Promotion of Science (JSPS)
- JP21K19335/MEXT | Japan Society for the Promotion of Science (JSPS)
- JP23K00395/MEXT | Japan Society for the Promotion of Science (JSPS)
- JP21wm0425017/Japan Agency for Medical Research and Development (AMED)
- JP21wm0525005/Japan Agency for Medical Research and Development (AMED)
- JP20dm0107122/Japan Agency for Medical Research and Development (AMED)
- JP22ama121052/Japan Agency for Medical Research and Development (AMED)
- JP22ama121054/Japan Agency for Medical Research and Development (AMED)
- JP21dm0207117/Japan Agency for Medical Research and Development (AMED)
- JPMJFR2061/MEXT | Japan Science and Technology Agency (JST)
- JP18H05416/Ministry of Education, Culture, Sports, Science and Technology (MEXT)
LinkOut - more resources
Full Text Sources
Research Materials